Status:
RECRUITING
Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence
Lead Sponsor:
Gazi University
Conditions:
Acupressure
Intensive Care Unit
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will be conducted in a randomized controlled experimental design to examine the effects of acupressure applied to patients treated in the intensive care unit on physiological parameters, pa...
Eligibility Criteria
Inclusion
- Have received intensive care treatment for at least 48 hours,
- Are 18 years of age or older,
- Have a Glasgow Coma Scale score of \>13,
- Can speak and write in Turkish,
- Have no psychiatric diagnosis,
- Have no communication problems,
- Have a VAS score of ≥1,
- Have a mean arterial pressure of ≥65,
- Have SpO2 of ≥85.
Exclusion
- Have previously received acupressure treatment,
- Have ulcers, necrotic tissue and signs and symptoms of infection at the points where pressure will be applied,
- Have used antihypertensives, beta-blockers and similar medications,
- Have sedation,
- Have respiratory support from the device,
- Have inotropic treatment (dopamine, steradin and others),
- Have analgesic treatment in their routine treatment will not be included in the study.
- Patients who were discharged during the study,
- Patients who died during the study,
- Patients who wanted to leave the study,
- Patients who started receiving sedation during the application,
- Patients who added antihypertensive, beta-blocker and similar drugs to their routine treatment during the application,
- Patients who received inotropic treatment (dopamine, steradin and others) during the application,
- Patients who started receiving analgesia treatment during the application,
- Patients who developed ulcers, necrotic tissue and infection at the points where pressure will be applied during the application,
- Patients who started receiving respiratory support from the device during the application,
- Patients who had a Glasgow Coma Scale score of ≤13, mean arterial pressure of ≤65 and SpO2 of ≤85 during the application will be excluded from the study.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06994715
Start Date
May 1 2025
End Date
January 31 2026
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ozlem Canbolat
Ankara, Turkey (Türkiye)